New laser approach aims to save sight in diabetic patients
NCT ID NCT07315802
First seen Jan 11, 2026 · Last updated Jun 23, 2026 · Updated 32 times
Summary
This study will test a new pattern of retinal laser treatment combined with anti-VEGF injections for people with proliferative diabetic retinopathy (PDR), a serious eye condition that can lead to blindness. Researchers plan to enroll 300 adults aged 18–70 with stable diabetes and PDR. The goal is to see if this laser pattern better preserves vision and reduces the need for additional treatments compared to standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROLIFERATIVE DIABETIC RETINOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eye and ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, 200030, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
argon laser photocoagulation combined with anti-VEGF injection
What this could lead to
If successful, this could offer a more targeted laser treatment that reduces vision loss and the need for additional procedures in people with advanced diabetic eye disease.
What could go wrong
This is an early-stage study (not yet recruiting) with no phase specified. The new laser pattern may not prove better than standard treatment, and risks include retinal burns or worsening vision.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.